Correlation between CpG methylation profiles and hormone receptor status in breast cancers. - Wikidata - awgldk - TriplyDB

Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

http://www.wikidata.org/entity/Q36393321

about

Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer Circadian disruption and breast cancer: an epigenetic link?Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers Array-based DNA methylation profiling for breast cancer subtype discrimination.DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles.DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.Neighborhood rough set reduction-based gene selection and prioritization for gene expression profile analysis and molecular cancer classification.Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients.Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer DNA methylation epigenotypes in breast cancer molecular subtypes.Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Epigenetics in breast and prostate cancer Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.DNA methylation and hormone receptor status in breast cancer.DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.Inherited and acquired alterations in development of breast cancer.The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study

P2860

Q24646396-DFD5A3CA-939B-4B8A-8052-4B45CC301C74 Q26738987-C894F650-9BFC-459E-B0E4-8DF27BBD6781 Q26798258-70127A40-B74C-40B1-885E-CAFF7056EAB5 Q27314528-D7623824-328E-4A6B-AD27-2D6D522017CE Q27694612-79E3A33A-D16E-47ED-BF88-32C2C038108A Q33570282-37E44DE4-5316-40E6-8ACE-E1AE6C51117D Q33582678-A3EC3829-6CDB-4F07-B55A-3D4CD95529B1 Q33636156-CF8D9452-6E0A-4194-A15E-45BE3059DA39 Q33689442-5637EBCE-BB50-4A60-B993-F1FE108AA7DA Q33816178-61283DC1-F304-4FB4-8850-22118F0D032B Q33817330-202C8C19-2B64-4B8D-9B01-585780529EF9 Q33818016-1519A331-D03A-45C3-AD64-EAACA61DE542 Q33878937-3DB3BE67-130A-46A0-8623-FFA8C4D847B1 Q33892868-7E18FB65-65B5-40EA-AB2C-9B1DDAF7B009 Q33960955-AD76066C-AD39-4C02-B045-5A53AA4BE046 Q33960985-65D08376-E350-4D36-9171-05276F49B5BB Q33961765-6A10C4DD-31D6-4E3B-9196-13D63900717A Q34303319-6214D195-D108-4963-942C-6ED4FF7C8B2F Q34305047-FF2927D7-E3E5-4C95-A53E-9EA8BE723A60 Q34989097-A2412E71-278A-4C00-B8BF-953ED6FA6E8A Q35000210-A40E7FF5-C48F-461C-9CF6-5B0CECFA4A93 Q35008011-E53DEE65-723C-475A-A989-5E48DC89D0E8 Q35152011-01526A5A-1A38-4592-9085-398C72B45B96 Q35163939-E0737090-5A22-4570-AA38-D73F5FCF439F Q35172269-3EAED2E3-56C6-499D-99CE-62F02CED1D8A Q35190483-767088DF-EFAA-452B-B254-3EA7101064A4 Q35624942-89F11322-7AC0-433A-B93E-07A250279F17 Q35801963-4F396D93-BC13-4F26-BB56-C1BC23145A2C Q35958967-B3E0BFC4-58EF-4FC0-BFB2-7274F6AA5485 Q36061986-7F427905-3E4F-4F07-9D34-BD0AC82C7E19 Q36355895-373FE199-D52C-4BBE-8AF0-8B6140272ED7 Q36545127-69E4FCB3-31B4-4E77-AB4C-D717A7B97235 Q36583742-E38DA531-CDD4-45F5-9424-C1CD41C09F04 Q36768855-D9A021E5-8B3F-4FAD-97DE-BD673E4107F5 Q36865048-13405D56-E5FC-400D-9CE9-A00E41CCD1B1 Q36925229-77EDA067-AB20-4DE6-8B37-0BB3FE5BA51D Q37177902-8FC4C66B-BE50-49A4-A550-71F5F8696244 Q37269445-B0D3694D-24AE-4F3C-B4C8-01A11B4E321E Q37285274-F6C7A5A4-2418-4321-B86B-54941CF5834C Q37308097-E799FD15-A51B-4DF7-A98A-1D8F7210EC3E

P2860

Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

http://www.wikidata.org/entity/Q36393321

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Correlation between CpG methyl ...... ptor status in breast cancers.

@ast

Correlation between CpG methyl ...... ptor status in breast cancers.

@en

type

label

Correlation between CpG methyl ...... ptor status in breast cancers.

@ast

Correlation between CpG methyl ...... ptor status in breast cancers.

@en

prefLabel

Correlation between CpG methyl ...... ptor status in breast cancers.

@ast

Correlation between CpG methyl ...... ptor status in breast cancers.

@en

P1433

Q36393321-8E19E188-D103-4770-BAB7-E4A5F1A3EA4E

P1476

Q36393321-EE3B09E6-850D-4A4D-AEB3-BD499D026A10

P2093

Q36393321-09B6345E-DAE2-418A-9868-D2A2895A0E2E

Q36393321-0F492E2A-0262-4ADD-BAFC-12578D5B5CDF

Q36393321-29491272-582A-47FF-8499-7E8961FB5E66

Q36393321-2DBDF172-3C97-41DA-996E-CC24F1EEE439

Q36393321-6DA5638C-31D3-4B2F-803E-B6132FC62C09

Q36393321-6E1A48B4-1F9B-4C8E-AB9F-013622AF0791

Q36393321-8532C513-7ED2-4FCA-ABA4-C7745C6CA931

Q36393321-88D2D32A-69C7-41E9-BCE8-EA5B764E126D

Q36393321-939F2C6C-34A4-4E55-8093-4AAE65A92426

Q36393321-9864B292-2214-4B2F-A9AF-F9A593020F58

P2860

Q36393321-0938AA64-865D-4764-B268-C3DC5E0F9D6F

Q36393321-15DEEA9F-E137-47F9-ABE3-1BC71F7F8498

Q36393321-1EA5BD3B-5E98-4029-813D-701C8548B125

Q36393321-2040B2AB-5F78-4686-9E70-E663AF3E2751

Q36393321-249C5879-8A54-4F07-BE8C-E0E65725D17F

Q36393321-270331F6-60B5-4D70-9E48-4F4DA9193D53

Q36393321-292D60D4-CDA4-4097-9C62-4B097A3AFBE9

Q36393321-3C075B27-94AB-4905-BBAE-58A75F522BD3

Q36393321-4364EF57-7C79-41DA-B203-8D7E3235BC4B

Q36393321-46052554-9EF2-4AE7-8960-E09D345C84C5

P2888

Q36393321-A196FAD9-03AA-4388-9A90-64CDDBFA1BB7

P304

Q36393321-5CBC5B11-BCB4-4D7C-AAAC-341CD4F1476C

P31

Q36393321-9ED7C6EE-818A-465F-95BA-EAFB1778E2FB

P356

Q36393321-18E9BAB4-88CB-4628-B4D8-2E7609FE4B71

P433

Q36393321-129D3C12-89ED-4FC5-9201-2B251B9BEFA5

P478

Q36393321-F59099B4-4124-4DDA-BC63-CA64B79654E7

P577

Q36393321-728C9EB2-0070-40D2-9442-84047971AAE5

P5875

Q36393321-1C6034EF-FD46-4DDF-8835-D7AB038AE4A1

P6179

Q36393321-0ADDC745-83C8-405B-AC7B-D767FF21B54A

P698

Q36393321-C7F1E1AD-5DAA-421D-8159-B49C92B49DF7

P932

Q36393321-86B17B26-26D4-4016-AA66-7098834C2799

P356

P1433

Breast Cancer Research

P1476

Correlation between CpG methyl ...... ptor status in breast cancers.

@en

P2093

Aysegul A Sahin

http://www.w3.org/2001/XMLSchema#string

Daniel G Rosen

http://www.w3.org/2001/XMLSchema#string

Jaroslav Jelinek

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre J Issa

http://www.w3.org/2001/XMLSchema#string

Jinsong Liu

http://www.w3.org/2001/XMLSchema#string

Kelly K Hunt

http://www.w3.org/2001/XMLSchema#string

Lanlan Shen

http://www.w3.org/2001/XMLSchema#string

Miao Huang

http://www.w3.org/2001/XMLSchema#string

Robert C Bast

http://www.w3.org/2001/XMLSchema#string

Shaoyi Huan

http://www.w3.org/2001/XMLSchema#string

P2860

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells

Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites

Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing

Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily

Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia.

p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma.

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

P2888

P304

R57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1762

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6075003

http://www.w3.org/2001/XMLSchema#string

P6179

1012833701

http://www.w3.org/2001/XMLSchema#string

P698

17764565

http://www.w3.org/2001/XMLSchema#string

P932

2206733

http://www.w3.org/2001/XMLSchema#string